In-Depth Analysis of the Liquid Biopsy Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

What Are the Projected Growth and Market Size Trends for the Liquid Biopsy Market?
Recently, the liquid biopsy market has witnessed a swift expansion. It is projected to increase from $1.25 billion in 2024 to $1.46 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.4%. The boost observed during the past years is largely due to advancements in cancer studies, non-invasive procedures, personalized treatments, regulatory sanctions, and early cancer detection initiatives.

Anticipating swift expansion in the upcoming years, the liquid biopsy market is projected to escalate to $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 17.2%. The predicted growth during the forecast period can be ascribed to the broadening applications in cancer monitoring, the advent of new technologies, companion diagnostics, and biomarker discovery. Key trends during the forecast term will focus on cancer detection and monitoring, therapeutic control, minimal residual disease (mrd) monitoring, and the application of liquid biopsy in non-oncological fields.

What Is Driving the Growth Trajectory of the Liquid Biopsy Market?
The growth of the liquid biopsy market is fuelled by government funds assigned for improving cancer detection. These funds aid researchers in discovering drugs, diagnosing, and treating diseases like Cancer. For example, in 2022, the National Institute of Health (NIH), a medical research agency in the US, was awarded a fund of $46.6 billion. Simultaneously, the National Cancer Institute (NCI), a cancer research agency in America, was granted $6.9 billion to push forward cancer research. As a result, government funding contributes towards the positive expansion of the liquid biopsy market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

Which Leading Companies Are Shaping the Growth of the Liquid Biopsy Market?
Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

What Are the Major Trends Shaping the Liquid Biopsy Market?
Businesses are swiftly embracing innovative market trends and centering mainly on sophisticated product introductions to fulfill the constantly growing demand for liquid biopsy goods and services, boost their income, and secure a competitive advantage. For instance, Laboratory Corporation of America Holdings, a healthcare company from the U.S., introduced the Labcorp Plasma Focus, a liquid biopsy test, in June 2023. The test is designed to detect cancer-related biomarkers in individuals with advanced or metastatic solid tumors. It inspects the cell-free DNA (cfDNA) in a patient's blood sample to create a genomic profile of the tumor. It thus allows oncologists to improve how they manage their patients' healthcare through the development of personalized, highly targeted therapy plans. Therefore, businesses are investing in the production of new products for the liquid biopsy market.

What Are the Key Segments of the Liquid Biopsy Market?
The liquid biopsy market covered in this report is segmented -

1) By Product: Assays Kits, Instruments, Services
2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics
3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

Subsegments:
1) By Assays Kits: cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays, Protein-based Assays
2) By Instruments: PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, Mass Spectrometry Instruments
3) By Services: Testing Services, Data Analysis Services, Laboratory Services, Custom Assay Development Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Which Region Dominates the Liquid Biopsy Market?
North America was the largest region in the liquid biopsy market in 2023. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Liquid Biopsy Global Market Report?

- Market Size Analysis: Analyze the Liquid Biopsy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Liquid Biopsy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Liquid Biopsy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Liquid Biopsy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2815

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.